Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.


TSX:CPH - Post by User

Bullboard Posts
Comment by Stylesson Mar 19, 2014 2:00pm
130 Views
Post# 22341887

RE:Wittman ignored by 36 ouch! Boards have spoken

RE:Wittman ignored by 36 ouch! Boards have spokenmy biggest problem with you is you accuse everyone of lying, but no one has made any statement that one can infer they are lying about.

Saying DND looks overvalued or it's stock trades like shi*t, isn't a fact. It's an opinion. You keep asking for proof, but most of the topcs that are being raise don't have that. They are opinions.

When i said at 9 bucks that the stock was getting expensive and there's too much risk in the stock given the Company is just a one drug wonder, you asked for proof. What proof exactly do you need? The company has one drug it makes all its money from. What more do you need to know or expect from someone? Weeks later, the stock got hammered because of that one drug risk with the lawsuit.

You're a very immature and not so knowledgable guy Truthseeker. Suggest you move along. 

Stocks going back to 7 btw!
Bullboard Posts